Full Press Release Details
Hai Tran, Chief Financial
BIOSCRIP STOCKHOLDERS
ELECT New Independent Director
Y. Jorden to board of directors
ELMSFORD, N.Y., May 14, 2014 - BioScrip, Inc. (NASDAQ:
BIOS) today announced that at BioScrip's 2014 Annual Meeting held on May 8, 2014, its stockholders voted to elect new independent
director Yon Y. Jorden, expanding the size of the Board of Directors from nine to ten members, nine of whom are independent and
all of whom are elected annually.
Ms. Jorden has more than a decade of leadership experience in
health care services and has served as Chief Financial Officer for several publicly-traded health care companies over her career,
including AdvancePCS, Oxford Health Plans, Inc. and Wellpoint, Inc. She also has additional expertise across the technology and
manufacturing industries. Throughout her career, Ms. Jorden has focused on complex financial transactions, including initial public
offerings and mergers and acquisitions, which will bring additional valuable perspective to the BioScrip Board. Ms. Jorden will
serve on BioScrip's Audit Committee and Management Development and Compensation Committee.
"Yon's extensive public company Board experience,
strong financial background and deep knowledge of healthcare will add considerable value to BioScrip's execution of its ongoing
strategic priorities," said Rick Smith, President and Chief Executive Officer of BioScrip. "We believe BioScrip is
a dynamic company with strong growth potential in the infusion industry. Since the beginning of the year, we have welcomed two
highly qualified independent directors to our Board, and we look forward to building on our recent success as we benefit from Yon's
perspective and expertise."
Ms. Jorden is a National Association of Corporate Directors
(NACD) Board Leadership Fellow and currently serves on the board of directors of Methodist Health System, a Texas-based not-for-profit
hospital system, and Maxwell Technologies, Inc., a publicly-traded manufacturer of energy storage and power delivery solutions.
She previously served on the board of directors of Magnetek, Inc. and U.S. Oncology.
Caldwell Partners assisted BioScrip's Board with its director
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion and
home care solutions. BioScrip partners with physicians, hospital systems, healthcare payors, and pharmaceutical manufacturers to
provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and
related healthcare infusion therapy services into the home or alternate- site setting. By collaborating with the full spectrum
of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by quality, customer service,
and values that promote positive outcomes and an enhanced quality of life for those it serves. BioScrip provides its infusion and
home care services from over 80 locations across 29 states.